CA2027596A1 - Compositions renfermant des acides hyaluronique complexes contenant du zinc ou du cobalt - Google Patents

Compositions renfermant des acides hyaluronique complexes contenant du zinc ou du cobalt

Info

Publication number
CA2027596A1
CA2027596A1 CA2027596A CA2027596A CA2027596A1 CA 2027596 A1 CA2027596 A1 CA 2027596A1 CA 2027596 A CA2027596 A CA 2027596A CA 2027596 A CA2027596 A CA 2027596A CA 2027596 A1 CA2027596 A1 CA 2027596A1
Authority
CA
Canada
Prior art keywords
zinc
cobalt
hyaluronic acid
complexes
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2027596A
Other languages
English (en)
Other versions
CA2027596C (fr
Inventor
Kalman Burger
Geza Takacsi Nagy
Ivan Rethey
Janos Illes
Bela Stefko
Erzsebet Neszmelyi
Istvan Gebhardt
Istvan Racz
Arpadne Kiraly
Viktoria Varkonyi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Richter Gedeon Vegyeszeti Gyar Nyrt
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2027596A1 publication Critical patent/CA2027596A1/fr
Application granted granted Critical
Publication of CA2027596C publication Critical patent/CA2027596C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • C08B37/00272-Acetamido-2-deoxy-beta-glucans; Derivatives thereof
    • C08B37/003Chitin, i.e. 2-acetamido-2-deoxy-(beta-1,4)-D-glucan or N-acetyl-beta-1,4-D-glucosamine; Chitosan, i.e. deacetylated product of chitin or (beta-1,4)-D-glucosamine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/27Zinc; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73Polysaccharides
    • A61K8/735Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0072Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/58Metal complex; Coordination compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
CA002027596A 1989-02-24 1990-02-20 Compositions renfermant des acides hyaluronique complexes contenant du zinc ou du cobalt Expired - Lifetime CA2027596C (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
HU89891A HU203372B (en) 1989-02-24 1989-02-24 Process for producing hyaluronic associates and pharmaceutical compositions and cosmetics comprising such active ingredient
HU891/89 1989-02-24
HUPCT/HU90/00013 1990-02-20
PCT/HU1990/000013 WO1990010020A1 (fr) 1989-02-24 1990-02-20 Nouvelles compositions contenant des associes d'acide hyaluronique et leur procede de preparation

Publications (2)

Publication Number Publication Date
CA2027596A1 true CA2027596A1 (fr) 1990-08-25
CA2027596C CA2027596C (fr) 2001-01-02

Family

ID=10951903

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002027596A Expired - Lifetime CA2027596C (fr) 1989-02-24 1990-02-20 Compositions renfermant des acides hyaluronique complexes contenant du zinc ou du cobalt

Country Status (33)

Country Link
US (1) US5554598A (fr)
EP (1) EP0413016B1 (fr)
JP (1) JP2571312B2 (fr)
KR (1) KR960015624B1 (fr)
CN (2) CN1051228C (fr)
AR (1) AR243538A1 (fr)
AT (1) ATE98964T1 (fr)
AU (1) AU623232B2 (fr)
BG (1) BG61515B2 (fr)
CA (1) CA2027596C (fr)
CZ (1) CZ281000B6 (fr)
DD (1) DD292263A5 (fr)
DE (1) DE69005394T2 (fr)
DK (1) DK0413016T3 (fr)
ES (1) ES2061016T3 (fr)
FI (1) FI101707B1 (fr)
GE (2) GEP19981358B (fr)
GR (1) GR1000869B (fr)
HK (1) HK1003003A1 (fr)
HU (2) HU203372B (fr)
IE (1) IE62408B1 (fr)
IL (1) IL93489A (fr)
LT (2) LT3806B (fr)
LV (2) LV10112B (fr)
MY (1) MY105168A (fr)
NO (1) NO301169B1 (fr)
PL (1) PL163417B1 (fr)
PT (1) PT93237B (fr)
RU (2) RU2099350C1 (fr)
SK (1) SK279530B6 (fr)
UA (2) UA39174C2 (fr)
WO (1) WO1990010020A1 (fr)
ZA (1) ZA901357B (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR920100122A (el) * 1991-04-05 1993-03-16 Ethicon Inc Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.
DE4115454A1 (de) * 1991-05-11 1992-11-12 Basf Ag Eisen-(iii)-hyaluronate
US5531716A (en) * 1993-09-29 1996-07-02 Hercules Incorporated Medical devices subject to triggered disintegration
IT1273742B (it) * 1994-08-01 1997-07-09 Lifegroup Spa Composizioni ad elevata bioadesivita' e mucoadesivita' utili per il trattamento di epitali e mucose
CN1064372C (zh) * 1994-08-26 2001-04-11 顾其胜 透明质酸钠制剂的制备方法
US6368356B1 (en) 1996-07-11 2002-04-09 Scimed Life Systems, Inc. Medical devices comprising hydrogel polymers having improved mechanical properties
HU225329B1 (en) * 1996-09-12 2006-09-28 Richter Gedeon Vegyeszet Use of zinc or cobalt hyaluronate associate for the manufacture of pharmaceutical compositions of antimicrobial activity
HU225991B1 (en) * 1997-04-29 2008-02-28 Richter Gedeon Nyrt Use of the zinc hyaluronate associate (complex) for the preparation of pharmaceutical compositions for oral use against peptic ulcer
US5906997A (en) * 1997-06-17 1999-05-25 Fzio Med, Inc. Bioresorbable compositions of carboxypolysaccharide polyether intermacromolecular complexes and methods for their use in reducing surgical adhesions
US6869938B1 (en) 1997-06-17 2005-03-22 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use in reducing adhesions
US7192984B2 (en) 1997-06-17 2007-03-20 Fziomed, Inc. Compositions of polyacids and polyethers and methods for their use as dermal fillers
JP2003089647A (ja) 1999-03-10 2003-03-28 Takada Seiyaku Kk 関節性疾患治療剤
US6566345B2 (en) 2000-04-28 2003-05-20 Fziomed, Inc. Polyacid/polyalkylene oxide foams and gels and methods for their delivery
US6913765B2 (en) 2001-03-21 2005-07-05 Scimed Life Systems, Inc. Controlling resorption of bioresorbable medical implant material
CZ12015U1 (cs) * 2002-01-18 2002-02-25 Cpn Spol. S R.O. Přípravek pro prevenci adheze bandáľe na ránu
RU2220729C2 (ru) * 2002-01-31 2004-01-10 Общество с ограниченной ответственностью "Научный Центр системных исследований и технологий 2000" Гелевая композиция, используемая в стоматологии
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
PT1536845E (pt) 2002-09-11 2007-06-01 Johnson & Johnson Medical Ltd Materiais de penso compreendendo complexos de polissacarídeos aniónicos com prata
RU2227742C1 (ru) * 2002-09-25 2004-04-27 Представительство фирмы "Гедеон Рихтер" на Волге Средство для профилактики послеоперационного спаечного процесса
HUP0303779A2 (en) * 2003-11-20 2006-02-28 Richter Gedeon Vegyeszet Pharmaceutical compositions containing hyaluronan complex for the treatment of sclerosis multiplex
RU2280041C1 (ru) * 2005-04-21 2006-07-20 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" Способ получения водорастворимых солевых комплексов гиалуроновой кислоты (варианты)
WO2006121210A1 (fr) * 2005-05-13 2006-11-16 Takata Seiyaku Co., Ltd. Agent d'amélioration de l'état de la peau
JPWO2006121209A1 (ja) * 2005-05-13 2008-12-18 高田製薬株式会社 湿疹・皮膚炎群治療剤
JP4220513B2 (ja) * 2005-12-01 2009-02-04 株式会社資生堂 カチオン化ヒアルロン酸
CN100348621C (zh) * 2005-12-02 2007-11-14 凌沛学 透明质酸铋及其制备方法和应用
CN1329414C (zh) * 2005-12-02 2007-08-01 凌沛学 透明质酸铋钾及其制备方法和应用
FR2918565B1 (fr) * 2007-07-12 2009-10-30 Biopharmex Holding Sa Hydrogel de carboxyalkylamide de chitosan, sa preparation et son utilisation cosmetique et dermatologique
ES2326721B1 (es) * 2008-01-04 2010-07-16 Endor Nanotechnologies, S.L. Conjugado de acido hialuronico para el tratamiento cosmetico y procedimiento de preparacion.
TWI383796B (zh) 2009-08-14 2013-02-01 Holy Stone Healthcare Co Ltd Use of hyaluronic acid mixture for the treatment and prevention of peptic ulcer and duodenal ulcer
TWI516269B (zh) 2009-08-14 2016-01-11 禾伸堂生技股份有限公司 使用於炎症性腸疾病(ibd)治療和預防之透明質酸混合物
HUP0900717A3 (en) * 2009-11-18 2012-02-28 Richter Gedeon Nyrt Pharmaceutical composition for urological use containing zinc hyaluronate
JP5728865B2 (ja) 2010-01-07 2015-06-03 株式会社リコー 放熱機構、及び放熱板の支え金具
WO2011129370A1 (fr) 2010-04-14 2011-10-20 キユーピー株式会社 Procédé pour produire un sel de métal d'acide hyaluronique, procédé pour produire un agent cosmétique contenant un sel de métal d'acide hyaluronique, et du hyaluronate de zinc et procédé pour produire celui-ci
ES2376680B8 (es) 2010-08-16 2013-04-30 Nylstar, S.A. Fibra textil cosmética, procedimiento de obtención y su empleo.
CN102552309B (zh) * 2010-12-15 2013-06-05 北京理工大学 一种透明质酸金的用途及其制备方法
JP5763953B2 (ja) * 2011-03-31 2015-08-12 ロート製薬株式会社 外用組成物
CN102961396A (zh) * 2012-12-17 2013-03-13 程玉李 透明质酸金属盐在制备治疗皮肤病药物中的应用、其药物组合物及其制备方法
US10449254B2 (en) 2013-11-03 2019-10-22 The Regents Of The University Of California Ionic liquids for transdermal drug delivery
JP6608620B2 (ja) * 2015-05-26 2019-11-20 ロート製薬株式会社 皮膚外用剤
JP7179354B2 (ja) * 2016-08-29 2022-11-29 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 皮膚処置のためのイオン種に基づく局所処方物
BR112019005391A2 (pt) 2016-09-21 2019-06-04 Nestlé Skin Health Sa métodos para preparar uma composição de hidrogel injetável esterilizada e para tratar cosmeticamente a pele, e, composição de hidrogel injetável esterilizada.
WO2019001784A1 (fr) 2017-06-28 2019-01-03 Nestlé Skin Health Sa Gel d'acide hyaluronique avec un cation divalent
HRP20240485T1 (hr) 2017-08-24 2024-07-05 Novo Nordisk A/S Pripravci glp-1 i njihova upotreba
PE20230819A1 (es) 2020-02-18 2023-05-19 Novo Nordisk As Composiciones y usos de glp-1
CN111647100B (zh) * 2020-07-14 2022-03-01 山东华熙海御生物医药有限公司 一种高分子量透明质酸锌的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US441973A (en) 1890-12-02 rapieff
US3074927A (en) * 1960-04-12 1963-01-22 Paul D Saltman Metallic complexes of reducing sugars
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
HU172831B (hu) * 1976-03-31 1978-12-28 Egyt Gyogyszervegyeszeti Gyar Sposob poluchenija kompleksov oligo- i poligalakturonnyk kislot s ionami zhiznenno vazhnykh metallov
US4303676A (en) 1980-03-21 1981-12-01 Balazs Endre A Hyaluronate based compositions and cosmetic formulations containing same
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
US4623539A (en) * 1983-02-04 1986-11-18 Tunc Deger C Nutrient barrier polysaccharide compositions and method of use
NO161573C (no) 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.
JPS61286310A (ja) * 1985-06-10 1986-12-16 Kanebo Ltd メ−クアツプ化粧料
US4746504A (en) * 1986-03-14 1988-05-24 Bio-Technology General Corp. Heavy metal salts of hyaluronic acid and their use as antimicrobial agents
AU600483B2 (en) * 1986-03-14 1990-08-16 Bio-Technology General Corporation Heavy metal salts of hyaluronic acid
US4742215A (en) * 1986-05-07 1988-05-03 Personal Computer Card Corporation IC card system
AU604542B2 (en) * 1987-03-19 1990-12-20 Arthropharm Pty Ltd Polysulphated polysaccharide complexes

Also Published As

Publication number Publication date
FI101707B (fi) 1998-08-14
GR900100137A (en) 1991-06-28
DD292263A5 (de) 1991-07-25
BG61515B2 (bg) 1997-10-31
GEP19971015B (en) 1997-05-30
LTIP1418A (en) 1995-05-25
LV10112B (en) 1995-02-20
ES2061016T3 (es) 1994-12-01
DE69005394D1 (de) 1994-02-03
CN1024557C (zh) 1994-05-18
ATE98964T1 (de) 1994-01-15
HU211465A9 (en) 1995-11-28
CN1086422A (zh) 1994-05-11
PL163417B1 (pl) 1994-03-31
DE69005394T2 (de) 1994-07-28
JPH03505231A (ja) 1991-11-14
KR960015624B1 (ko) 1996-11-18
AU623232B2 (en) 1992-05-07
LT3806B (en) 1996-03-25
RU2099350C1 (ru) 1997-12-20
IE900637L (en) 1990-08-24
HUT53128A (en) 1990-09-28
WO1990010020A1 (fr) 1990-09-07
PL283942A1 (en) 1991-01-28
LTIP1474A (en) 1995-06-26
EP0413016A1 (fr) 1991-02-20
CN1045394A (zh) 1990-09-19
FI101707B1 (fi) 1998-08-14
GEP19981358B (en) 1998-08-25
CZ281000B6 (cs) 1996-05-15
KR920700231A (ko) 1992-02-19
MY105168A (en) 1994-08-30
UA26324A (uk) 1999-08-30
LV10965B (en) 1996-08-20
NO301169B1 (no) 1997-09-22
IL93489A (en) 1994-05-30
LV10112A (lv) 1994-05-10
SK85790A3 (en) 1998-12-02
SK279530B6 (sk) 1998-12-02
CN1051228C (zh) 2000-04-12
AR243538A1 (es) 1993-08-31
CA2027596C (fr) 2001-01-02
IE62408B1 (en) 1995-01-25
PT93237A (pt) 1990-08-31
JP2571312B2 (ja) 1997-01-16
DK0413016T3 (da) 1994-02-14
NO904584D0 (no) 1990-10-23
FI905109A0 (fi) 1990-10-17
RU2021304C1 (ru) 1994-10-15
HK1003003A1 (en) 1998-09-30
NO904584L (no) 1990-12-21
LT3873B (en) 1996-04-25
LV10965A (lv) 1995-12-20
UA39174C2 (uk) 2001-06-15
US5554598A (en) 1996-09-10
PT93237B (pt) 1996-01-31
AU5108890A (en) 1990-09-26
ZA901357B (en) 1990-11-28
GR1000869B (el) 1993-03-16
HU203372B (en) 1991-07-29
CZ85790A3 (en) 1995-02-15
EP0413016B1 (fr) 1993-12-22

Similar Documents

Publication Publication Date Title
CA2027596A1 (fr) Compositions renfermant des acides hyaluronique complexes contenant du zinc ou du cobalt
CA2016659A1 (fr) Compose stabilise contenant un facteur de croissance epidermique
CA2068324A1 (fr) Compositions peptidiques renfermant un metal et methodes de stimulation de la croissance des cheveux
IE830870L (en) Oral hygiene compositions
CS653586A3 (en) Pharmaceutical containing 7-isopropoxyisoflavone
EP0369356A3 (fr) Compositions pour le traitement des cheveux ayant des propriétés de fixation durable des cheveux
CA2147341A1 (fr) Composition pour le traitement de la peau comprenant de l'acide l-lactique et du n-acetyle-l-cysteine
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
EP0166440A3 (fr) Compostion antiacide
UA66766C2 (uk) Антимікробна фармацевтична композиція на основі гіалуронатного асоціату цинку або кобальту, спосіб її одержання та спосіб лікування
HUT52083A (en) Herbicidal compositions comprising cyclohexenone oxymetres as active ingredient and process for producing the active ingredients
CA2286756A1 (fr) Utilisation d'hyaluronate de zinc pour traiter un ulcere gastro-duodenal
UA40636C2 (uk) Фармацевтична композиція для одержання стабільного порошку, яка містить як активний компонент асоціацію ацетилсаліцилової кислоти та метоклопраміду, фармацевтичний препарат у формі порошку та спосіб одержання цього препарату
CA2127472A1 (fr) Nouveaux derives de l'adenosine; methodes de preparation; compositions pharmaceutiques a base de ces derives
HUT55598A (en) Fungicidal composition comprising new amino acid amide derivatives as active ingredient and process for producing the active ingredients
CA2016221A1 (fr) Composes
CA2061870A1 (fr) Compositions medicinales utilisees comme cremes hydratantes et dans le traitement de l'eczema
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
HUT54289A (en) Fungicidal compositions comprising guanidine derivatives as active ingredient and process for producing the active ingredients
HUT47124A (en) Process for producing pharmaceutical compositions comprising organic platinum complex as active ingredient and the active ingredients
IE781610L (en) Antithrombotic composition
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
GEP20032968B (en) Use of Ketolides in Pharmaceutical Compositions for Preventing Thrombotic Arterial Complications Linked to Atherosclerosis
HU900075D0 (en) Herbicid composition comprising sulfonyl-urea as active ingredient and process for preparation thereof
HUT46364A (en) Process for producing 1,12-dihydroxy-1,6,12,13-tetraaza-dicyclodocosane-2,5,13,16-tetron and pharmaceutical compositions comprising this compound as active ingredient

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry